Serum Reactivity
Serum Reactivity - Related Videos
05:59
Determining the Reactivity and Titre of Serum using a Haemagglutination Assay
0 Views •
Cited by 3 •
2010
Haemagglutination is a form of agglutination where antibodies bind to red blood cells. Red blood cells are both readily available and the results are readily observable using the naked eye. This video demonstrates the steps involved in a haemagglutination assay, interpreting the results and determining the titre.
03:35
Thiobarbituric Acid-Reactive Substances Assay to Assess Oxidative Stress in Human Serum
0 Views •
2025
This video demonstrates the thiobarbituric acid reactive substances (TBARS) assay to assess oxidative stress in biological samples.
09:08
Detecting Reactive Oxygen Species
0 Views •
2023
Reactive oxygen species are chemically active, oxygen-derived molecules capable of oxidizing other molecules. Because of their reactive nature, there are many deleterious effects associated with unchecked ROS production, including structural damage to DNA and other biological molecules. However, ROS can also be mediators of physiological signaling. There is accumulating evidence that ROS play significant roles in everything from activation of transcription factors to the mediation of...
01:18
Reactivity of Enols
0 Views •
2023
Enols are a class of compounds where a hydroxyl group is attached to a carbon–carbon double bond, which implies that it is a vinyl alcohol. A carbonyl compound with an α hydrogen undergoes keto–enol tautomerism and remains in equilibrium with its tautomer, the enol form. Usually, the keto tautomer is present in a higher concentration than the enol tautomer due to the higher bond energy of C=O compared to C=C. Moreover, the direction of the keto–enol equilibrium is governed by factors like...
00:42
Cross-reactivity
0 Views •
2025
Overview The ability of a single antibody to recognize multiple structurally similar epitopes is an important immune defense strategy that enables the host to efficiently defend against many potentially threatening pathogens. However, cross-reactivity also elicits allergy symptoms against related allergens. It is increasingly important to understand the principles of cross-reactivity, as antibodies are actively being developed as therapeutic modalities for diverse diseases, including cancer.
FAQs
Complement can amplify antibody-mediated target destruction, but it is not the same as antibody binding itself. In a serum-reactivity measurement, antibodies first recognize microbial antigens; complement may then contribute to eliminating the recognized target. Distinguishing these functions helps researchers interpret whether an assay primarily detects antigen recognition or a downstream immune effect.
Different assays reveal different aspects of the response. Agglutination detects visible clumping after antibodies bind particulate antigens, enzyme-linked immunosorbent assays detect binding through an enzyme-based signal, and neutralization tests assess whether serum can block a relevant microbial effect. Choosing among them depends on whether the goal is to measure binding, visible aggregation, or functional inhibition.
Cross-reactive antibodies can bind antigens shared by related microbes or encountered through another immune exposure. As a result, a positive signal may indicate prior infection, vaccination, or nonspecific recognition rather than ongoing disease. Controls and clinical context are therefore necessary to separate evidence of immune exposure from evidence of current infection.
Interpretation should begin with the assay's controls, then consider what the test actually measures and how the result fits the individual's clinical context. A binding signal, for example, does not automatically establish neutralization or active infection. This stepwise reading reduces overinterpretation and makes comparisons among samples more meaningful.
Researchers compare antibody reactivity after vaccination with the response patterns measured in serum samples. Such testing can indicate whether vaccination generated detectable recognition of selected microbial antigens, while neutralization assays can add functional information when included. Results should still be interpreted carefully, because detectable antibodies do not by themselves distinguish vaccine-induced antibodies from antibodies arising after infection unless study design and clinical context support that interpretation.
At the population level, results can estimate seroprevalence, meaning the proportion of people with detectable evidence of immune exposure, and can help compare responses among groups. These measurements are useful for describing exposure patterns or evaluating vaccine-related responses. Without additional context, however, they do not identify when exposure occurred or confirm that infection is currently active.